"HealthLinx will receive a royalty of approximately $70 per test subject to exchange rates"http://imagesignal.comsec.com.au/asxdata/20100224/pdf/01040602.pdf
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025